Aptevo Therapeutics's market cap is currently $4.97M. The company's EPS TTM is $-452.264; its P/E ratio is ―; Aptevo Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-4.21. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 3.11M	$ 12.29M	$ 4.31M
Gross Profit	$ 0.00	$ -567.00K	$ 2.21M	$ -6.70M	$ -13.54M
Operating Income	$ -24.60M	$ -28.88M	$ -28.64M	$ -21.40M	$ -27.49M
EBITDA	$ -24.60M	$ -28.31M	$ -27.74M	$ -20.26M	$ -26.09M
Net Income	$ -24.13M	$ -17.41M	$ 42.67M	$ -27.31M	$ -18.45M
Balance Sheet
Cash & Short-Term Investments	$ 8.71M	$ 16.90M	$ 22.64M	$ 45.04M	$ 39.98M
Total Assets	$ 15.59M	$ 24.84M	$ 34.22M	$ 56.60M	$ 53.55M
Total Debt	$ 4.63M	$ 5.40M	$ 9.54M	$ 16.71M	$ 27.41M
Net Debt	$ -4.08M	$ -11.51M	$ -13.10M	$ -28.33M	$ -12.56M
Total Liabilities	$ 10.84M	$ 12.62M	$ 16.24M	$ 55.38M	$ 36.95M
Stockholders' Equity	$ 4.75M	$ 12.22M	$ 17.97M	$ 1.22M	$ 16.59M
Cash Flow
Free Cash Flow	$ -23.79M	$ -11.73M	$ -21.05M	$ -22.39M	$ -29.41M
Operating Cash Flow	$ -23.79M	$ -11.73M	$ -21.02M	$ -21.68M	$ -29.32M
Investing Cash Flow	$ 0.00	$ 0.00	$ -29.00K	$ -713.00K	$ 28.03M
Financing Cash Flow	$ 15.60M	$ 6.00M	$ -2.62M	$ 26.16M	$ 23.87M

Currency in USD

Aptevo Therapeutics Earnings and Revenue History

Income Statement >

Aptevo Therapeutics Debt to Assets

Balance Sheet >

Aptevo Therapeutics Cash Flow

Cash Flow >

Aptevo Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing